Literature DB >> 23439561

NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.

Xiaoxu Zhou1, Dan Li, Murray B Resnick, Jack Wands, Weibiao Cao.   

Abstract

The mechanisms of progression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA) are not known. Cycloxygenase-2 (COX-2)-derived prostaglandin E₂ (PGE₂) has been shown to be important in esophageal tumorigenesis. We have shown that COX-2 mediates acid-induced PGE₂ production. The prostaglandin E synthase (PGES) responsible for acid-induced PGE2 production in BE, however, is not known. We found that microsomal PGES1 (mPGES1), mPGES2, and cytosolic PGES (cPGES) were present in FLO EA cells. Pulsed acid treatment significantly increased mPGES1 mRNA and protein levels but had little or no effect on mPGES2 or cPGES mRNA. Knockdown of mPGES1 by mPGES1 small interfering RNA (siRNA) blocked acid-induced increase in PGE2 production and thymidine incorporation. Knockdown of NADPH oxidase, NOX5-S, a variant lacking calcium-binding domains, by NOX5 siRNA significantly inhibited acid-induced increase in mPGES1 expression, thymidine incorporation, and PGE2 production. Overexpression of NOX5-S significantly increased the luciferase activity in FLO cells transfected with a nuclear factor κB (NF-κB) in vivo activation reporter plasmid pNF-κB-Luc. Knockdown of NF-κB1 p50 by p50 siRNA significantly decreased acid-induced increase in mPGES1 expression, thymidine incorporation, and PGE₂ production. Two novel NF-κB binding elements, GGAGTCTCCC and CGGGACACCC, were identified in the mPGES1 gene promoter. We conclude that mPGES1 mediates acid-induced increase in PGE₂ production and cell proliferation. Acid-induced mPGES1 expression depends on activation of NOX5-S and NF-κB1 p50. Microsomal PGES1 may be a potential target to prevent or treat EA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439561      PMCID: PMC3629825          DOI: 10.1124/mol.112.083287

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  55 in total

Review 1.  Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer?

Authors:  Ashkan Farhadi; Jeremy Fields; Ali Banan; Ali Keshavarzian
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

2.  Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer.

Authors:  K Yoshimatsu; N K Altorki; D Golijanin; F Zhang; P J Jakobsson; A J Dannenberg; K Subbaramaiah
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

Review 3.  NF-kappaB in cancer: from innocent bystander to major culprit.

Authors:  Michael Karin; Yixue Cao; Florian R Greten; Zhi-Wei Li
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

4.  Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.

Authors:  R F Souza; K Shewmake; D G Beer; B Cryer; S J Spechler
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

Review 5.  Prostaglandin E synthase.

Authors:  Makoto Murakami; Yoshihito Nakatani; Toshihiro Tanioka; Ichiro Kudo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

6.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

Authors:  H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

Review 7.  The changing epidemiology of esophageal cancer.

Authors:  W J Blot; J K McLaughlin
Journal:  Semin Oncol       Date:  1999-10       Impact factor: 4.929

8.  Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis.

Authors:  T Tanioka; Y Nakatani; N Semmyo; M Murakami; I Kudo
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

9.  Identification and characterization of a novel type of membrane-associated prostaglandin E synthase.

Authors:  Naomi Tanikawa; Yoshihiro Ohmiya; Hiroaki Ohkubo; Katsuyuki Hashimoto; Kenji Kangawa; Masami Kojima; Seiji Ito; Kikuko Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2002-03-08       Impact factor: 3.575

10.  Expression of microsomal prostaglandin E synthase-1 in human hepatocelluar carcinoma.

Authors:  Yasushi Takii; Seigo Abiru; Hikaru Fujioka; Minoru Nakamura; Atsumasa Komori; Masahiro Ito; Ken Taniguchi; Manabu Daikoku; Yumi Meda; Kazuyuki Ohata; Koji Yano; Shinji Shimoda; Hiroshi Yatsuhashi; Hiromi Ishibashi; Kiyoshi Migita
Journal:  Liver Int       Date:  2007-09       Impact factor: 5.828

View more
  8 in total

Review 1.  Microbiome, innate immunity, and esophageal adenocarcinoma.

Authors:  Jonathan Baghdadi; Noami Chaudhary; Zhiheng Pei; Liying Yang
Journal:  Clin Lab Med       Date:  2014-09-26       Impact factor: 1.935

Review 2.  Enzymatic regulation and functional relevance of NOX5.

Authors:  Feng Chen; Yusi Wang; Scott Barman; David J R Fulton
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 3.  Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

Authors:  Panagiotis Tsibouris; Erasmia Vlachou; Peter Edward Thomas Isaacs
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-02-06

4.  Role of intracellular calcium and NADPH oxidase NOX5-S in acid-induced DNA damage in Barrett's cells and Barrett's esophageal adenocarcinoma cells.

Authors:  Dan Li; Weibiao Cao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

5.  Regulation of NADPH oxidase 5 by protein kinase C isoforms.

Authors:  Feng Chen; Yanfang Yu; Steven Haigh; John Johnson; Rudolf Lucas; David W Stepp; David J R Fulton
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Effect of Proton Pump Inhibitor Therapy on NOX5, mPGES1 and iNOS expression in Barrett's Esophagus.

Authors:  Dan Li; Deepthi Deconda; Aihua Li; Fadlallah Habr; Weibiao Cao
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 7.  The enzymology of the human prostanoid pathway.

Authors:  Roger Gregory Biringer
Journal:  Mol Biol Rep       Date:  2020-05-19       Impact factor: 2.316

8.  Induction of Cyclooxygenase-2 by Overexpression of the Human NADPH Oxidase 5 (NOX5) Gene in Aortic Endothelial Cells.

Authors:  Javier Marqués; Adriana Cortés; Álvaro Pejenaute; Eduardo Ansorena; Gloria Abizanda; Felipe Prósper; Juan José Martínez-Irujo; Carlos de Miguel; Guillermo Zalba
Journal:  Cells       Date:  2020-03-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.